v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Jun. 27, 2026
Jun. 28, 2025
Revenues        
Total revenues $ 11,994 $ 10,855 $ 22,999 $ 21,219
Costs and operating expenses:        
Selling, general and administrative expenses 2,333 2,140 4,514 4,218
Research and development expenses 364 352 700 695
Restructuring and other costs 98 82 147 180
Total costs and operating expenses 9,907 9,021 19,049 17,668
Operating income 2,087 1,834 3,950 3,551
Interest income     440 501
Interest expense     (755) (707)
Other income/(expense)     22 (16)
Income before income taxes 1,924 1,709 3,658 3,329
Benefit from/(provision for) income taxes (167) (92) (238) (187)
Equity in earnings/(losses) of unconsolidated entities (15) 2 (23) (12)
Net income 1,741 1,618 3,397 3,130
Less: net income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest 5 2 10 6
Net income attributable to Thermo Fisher Scientific Inc. $ 1,736 $ 1,617 $ 3,387 $ 3,124
Earnings per share attributable to Thermo Fisher Scientific Inc.        
Basic (in dollars per share) $ 4.68 $ 4.28 $ 9.11 $ 8.27
Diluted (in dollars per share) $ 4.68 $ 4.28 $ 9.10 $ 8.26
Weighted average shares        
Basic (in shares) 371 378 372 378
Diluted (in shares) 371 378 372 378
Product revenues        
Revenues        
Total revenues $ 6,823 $ 6,249 $ 13,100 $ 12,229
Costs and operating expenses:        
Cost of revenues 3,462 3,239 6,723 6,364
Service revenues        
Revenues        
Total revenues 5,171 4,605 9,899 8,990
Costs and operating expenses:        
Cost of revenues $ 3,650 $ 3,207 $ 6,964 $ 6,212